Global Immuno-Cell Therapy Market Growth (Status and Outlook) 2021-2026
According to this latest study, the 2021 growth of Immuno-Cell Therapy will have significant change from previous year. By the most conservative estimates of global Immuno-Cell Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Immuno-Cell Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Passive Immune (NK, LAK etc)
Active Immune
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immuno-Cell Therapy Market Size 2016-2026
2.1.2 Immuno-Cell Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Immuno-Cell Therapy Segment by Type
2.2.1 Passive Immune (NK, LAK etc)
2.2.2 Passive Immune (NK, LAK etc)
2.3 Immuno-Cell Therapy Market Size by Type
2.3.1 Global Immuno-Cell Therapy Market Size CAGR by Type
2.3.2 Global Immuno-Cell Therapy Market Size Market Share by Type (2016-2021)
2.4 Immuno-Cell Therapy Segment by Application
2.4.1 Oncology
2.4.2 Cardiovascular Disease (CVD)
2.4.3 Orthopedic
2.4.4 Wound Healing
2.4.5 Others
2.5 Immuno-Cell Therapy Market Size by Application
2.5.1 Global Immuno-Cell Therapy Market Size CAGR by Application
2.5.2 Global Immuno-Cell Therapy Market Size Market Share by Application (2016-2021)
3 Immuno-Cell Therapy Market Size by Players
3.1 Immuno-Cell Therapy Market Size Market Share by Players
3.1.1 Global Immuno-Cell Therapy Revenue by Players (2019-2021E)
3.1.2 Global Immuno-Cell Therapy Revenue Market Share by Players (2019-2021E)
3.2 Global Immuno-Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Immuno-Cell Therapy by Regions
4.1 Immuno-Cell Therapy Market Size by Regions (2016-2021)
4.2 Americas Immuno-Cell Therapy Market Size Growth (2016-2021)
4.3 APAC Immuno-Cell Therapy Market Size Growth (2016-2021)
4.4 Europe Immuno-Cell Therapy Market Size Growth (2016-2021)
4.5 Middle East & Africa Immuno-Cell Therapy Market Size Growth (2016-2021)
5 Americas
5.1 Americas Immuno-Cell Therapy Market Size by Country (2016-2021)
5.2 Americas Immuno-Cell Therapy Market Size by Type (2016-2021)
5.3 Americas Immuno-Cell Therapy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immuno-Cell Therapy Market Size by Region (2016-2021)
6.2 APAC Immuno-Cell Therapy Market Size by Type (2016-2021)
6.3 APAC Immuno-Cell Therapy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Immuno-Cell Therapy by Country (2016-2021)
7.2 Europe Immuno-Cell Therapy Market Size by Type (2016-2021)
7.3 Europe Immuno-Cell Therapy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Immuno-Cell Therapy by Region (2016-2021)
8.2 Middle East & Africa Immuno-Cell Therapy Market Size by Type (2016-2021)
8.3 Middle East & Africa Immuno-Cell Therapy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Immuno-Cell Therapy Market Forecast
10.1 Global Immuno-Cell Therapy Forecast by Regions (2021-2026)
10.1.1 Global Immuno-Cell Therapy Forecast by Regions (2021-2026)
10.1.2 Americas Immuno-Cell Therapy Forecast
10.1.3 APAC Immuno-Cell Therapy Forecast
10.1.4 Europe Immuno-Cell Therapy Forecast
10.1.5 Middle East & Africa Immuno-Cell Therapy Forecast
10.2 Americas Immuno-Cell Therapy Forecast by Countries (2021-2026)
10.2.1 United States Immuno-Cell Therapy Market Forecast
10.2.2 Canada Immuno-Cell Therapy Market Forecast
10.2.3 Mexico Immuno-Cell Therapy Market Forecast
10.2.4 Brazil Immuno-Cell Therapy Market Forecast
10.3 APAC Immuno-Cell Therapy Forecast by Region (2021-2026)
10.3.1 China Immuno-Cell Therapy Market Forecast
10.3.2 Japan Immuno-Cell Therapy Market Forecast
10.3.3 Korea Immuno-Cell Therapy Market Forecast
10.3.4 Southeast Asia Immuno-Cell Therapy Market Forecast
10.3.5 India Immuno-Cell Therapy Market Forecast
10.3.6 Australia Immuno-Cell Therapy Market Forecast
10.4 Europe Immuno-Cell Therapy Forecast by Country (2021-2026)
10.4.1 Germany Immuno-Cell Therapy Market Forecast
10.4.2 France Immuno-Cell Therapy Market Forecast
10.4.3 UK Immuno-Cell Therapy Market Forecast
10.4.4 Italy Immuno-Cell Therapy Market Forecast
10.4.5 Russia Immuno-Cell Therapy Market Forecast
10.5 Middle East & Africa Immuno-Cell Therapy Forecast by Region (2021-2026)
10.5.1 Egypt Immuno-Cell Therapy Market Forecast
10.5.2 South Africa Immuno-Cell Therapy Market Forecast
10.5.3 Israel Immuno-Cell Therapy Market Forecast
10.5.4 Turkey Immuno-Cell Therapy Market Forecast
10.5.5 GCC Countries Immuno-Cell Therapy Market Forecast
10.6 Global Immuno-Cell Therapy Forecast by Type (2021-2026)
10.8 Global Immuno-Cell Therapy Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 MEDINET Co
11.1.1 MEDINET Co Company Information
11.1.2 MEDINET Co Immuno-Cell Therapy Product Offered
11.1.3 MEDINET Co Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 MEDINET Co Main Business Overview
11.1.5 MEDINET Co Latest Developments
11.2 Erytech
11.2.1 Erytech Company Information
11.2.2 Erytech Immuno-Cell Therapy Product Offered
11.2.3 Erytech Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Erytech Main Business Overview
11.2.5 Erytech Latest Developments
11.3 Seta Clinic Group
11.3.1 Seta Clinic Group Company Information
11.3.2 Seta Clinic Group Immuno-Cell Therapy Product Offered
11.3.3 Seta Clinic Group Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Seta Clinic Group Main Business Overview
11.3.5 Seta Clinic Group Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Immuno-Cell Therapy Product Offered
11.4.3 Takeda Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 SBI Holdings
11.5.1 SBI Holdings Company Information
11.5.2 SBI Holdings Immuno-Cell Therapy Product Offered
11.5.3 SBI Holdings Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 SBI Holdings Main Business Overview
11.5.5 SBI Holdings Latest Developments
11.6 Oxford BioTherapeutics
11.6.1 Oxford BioTherapeutics Company Information
11.6.2 Oxford BioTherapeutics Immuno-Cell Therapy Product Offered
11.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Oxford BioTherapeutics Main Business Overview
11.6.5 Oxford BioTherapeutics Latest Developments
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Information
11.7.2 Fate Therapeutics Immuno-Cell Therapy Product Offered
11.7.3 Fate Therapeutics Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Fate Therapeutics Main Business Overview
11.7.5 Fate Therapeutics Latest Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Information
11.8.2 Gilead Sciences Immuno-Cell Therapy Product Offered
11.8.3 Gilead Sciences Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Gilead Sciences Main Business Overview
11.8.5 Gilead Sciences Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Immuno-Cell Therapy Product Offered
11.9.3 Novartis Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Osiris
11.10.1 Osiris Company Information
11.10.2 Osiris Immuno-Cell Therapy Product Offered
11.10.3 Osiris Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Osiris Main Business Overview
11.10.5 Osiris Latest Developments
11. Vericel Corporation
11.11.1 Vericel Corporation Company Information
11.11.2 Vericel Corporation Immuno-Cell Therapy Product Offered
11.11.3 Vericel Corporation Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Vericel Corporation Main Business Overview
11.11.5 Vericel Corporation Latest Developments
11.12 Fujifilm Cellular Dynamics
11.12.1 Fujifilm Cellular Dynamics Company Information
11.12.2 Fujifilm Cellular Dynamics Immuno-Cell Therapy Product Offered
11.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Fujifilm Cellular Dynamics Main Business Overview
11.12.5 Fujifilm Cellular Dynamics Latest Developments
11.13 JCR Pharmaceuticals
11.13.1 JCR Pharmaceuticals Company Information
11.13.2 JCR Pharmaceuticals Immuno-Cell Therapy Product Offered
11.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 JCR Pharmaceuticals Main Business Overview
11.13.5 JCR Pharmaceuticals Latest Developments
11.14 Beike Biotechnology
11.14.1 Beike Biotechnology Company Information
11.14.2 Beike Biotechnology Immuno-Cell Therapy Product Offered
11.14.3 Beike Biotechnology Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Beike Biotechnology Main Business Overview
11.14.5 Beike Biotechnology Latest Developments
11.15 Golden Meditech
11.15.1 Golden Meditech Company Information
11.15.2 Golden Meditech Immuno-Cell Therapy Product Offered
11.15.3 Golden Meditech Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Golden Meditech Main Business Overview
11.15.5 Golden Meditech Latest Developments
11.16 Guanhao Biotech
11.16.1 Guanhao Biotech Company Information
11.16.2 Guanhao Biotech Immuno-Cell Therapy Product Offered
11.16.3 Guanhao Biotech Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Guanhao Biotech Main Business Overview
11.16.5 Guanhao Biotech Latest Developments
11.17 Beroni Group
11.17.1 Beroni Group Company Information
11.17.2 Beroni Group Immuno-Cell Therapy Product Offered
11.17.3 Beroni Group Immuno-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Beroni Group Main Business Overview
11.17.5 Beroni Group Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Immuno-Cell Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Passive Immune (NK, LAK etc)
Table 3. Major Players of Active Immune
Table 4. Immuno-Cell Therapy Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Immuno-Cell Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Immuno-Cell Therapy Market Size Market Share by Type (2016-2021)
Table 7. Immuno-Cell Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Immuno-Cell Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Immuno-Cell Therapy Market Size Market Share by Application (2016-2021)
Table 10. Global Immuno-Cell Therapy Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Immuno-Cell Therapy Revenue Market Share by Players (2019-2021E)
Table 12. Immuno-Cell Therapy Key Players Head office and Products Offered
Table 13. Immuno-Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Immuno-Cell Therapy Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Immuno-Cell Therapy Market Size Market Share by Regions 2016-2021
Table 18. Americas Immuno-Cell Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Immuno-Cell Therapy Market Size Market Share by Country (2016-2021)
Table 20. Americas Immuno-Cell Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Immuno-Cell Therapy Market Size Market Share by Type (2016-2021)
Table 22. Americas Immuno-Cell Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Immuno-Cell Therapy Market Size Market Share by Application (2016-2021)
Table 24. APAC Immuno-Cell Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Immuno-Cell Therapy Market Size Market Share by Region (2016-2021)
Table 26. APAC Immuno-Cell Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Immuno-Cell Therapy Market Size Market Share by Type (2016-2021)
Table 28. APAC Immuno-Cell Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Immuno-Cell Therapy Market Size Market Share by Application (2016-2021)
Table 30. Europe Immuno-Cell Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Immuno-Cell Therapy Market Size Market Share by Country (2016-2021)
Table 32. Europe Immuno-Cell Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Immuno-Cell Therapy Market Size Market Share by Type (2016-2021)
Table 34. Europe Immuno-Cell Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Immuno-Cell Therapy Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Immuno-Cell Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Immuno-Cell Therapy Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Immuno-Cell Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Immuno-Cell Therapy Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Immuno-Cell Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Immuno-Cell Therapy Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Immuno-Cell Therapy
Table 43. Key Application and Potential Industries of Immuno-Cell Therapy
Table 44. Key Challenges of Immuno-Cell Therapy
Table 45. Key Trends of Immuno-Cell Therapy
Table 46. Global Immuno-Cell Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Immuno-Cell Therapy Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Immuno-Cell Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Immuno-Cell Therapy Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Immuno-Cell Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Immuno-Cell Therapy Market Size Market Share Forecast by Application (2021-2026)
Table 52. MEDINET Co Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 53. MEDINET Co Immuno-Cell Therapy Product Offered
Table 54. MEDINET Co Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. MEDINET Co Main Business
Table 56. MEDINET Co Latest Developments
Table 57. Erytech Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 58. Erytech Immuno-Cell Therapy Product Offered
Table 59. Erytech Main Business
Table 60. Erytech Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Erytech Latest Developments
Table 62. Seta Clinic Group Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 63. Seta Clinic Group Immuno-Cell Therapy Product Offered
Table 64. Seta Clinic Group Main Business
Table 65. Seta Clinic Group Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Seta Clinic Group Latest Developments
Table 67. Takeda Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 68. Takeda Immuno-Cell Therapy Product Offered
Table 69. Takeda Main Business
Table 70. Takeda Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Takeda Latest Developments
Table 72. SBI Holdings Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 73. SBI Holdings Immuno-Cell Therapy Product Offered
Table 74. SBI Holdings Main Business
Table 75. SBI Holdings Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. SBI Holdings Latest Developments
Table 77. Oxford BioTherapeutics Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 78. Oxford BioTherapeutics Immuno-Cell Therapy Product Offered
Table 79. Oxford BioTherapeutics Main Business
Table 80. Oxford BioTherapeutics Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Oxford BioTherapeutics Latest Developments
Table 82. Fate Therapeutics Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 83. Fate Therapeutics Immuno-Cell Therapy Product Offered
Table 84. Fate Therapeutics Main Business
Table 85. Fate Therapeutics Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. Fate Therapeutics Latest Developments
Table 87. Gilead Sciences Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 88. Gilead Sciences Immuno-Cell Therapy Product Offered
Table 89. Gilead Sciences Main Business
Table 90. Gilead Sciences Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Gilead Sciences Latest Developments
Table 92. Novartis Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 93. Novartis Immuno-Cell Therapy Product Offered
Table 94. Novartis Main Business
Table 95. Novartis Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Novartis Latest Developments
Table 97. Osiris Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 98. Osiris Immuno-Cell Therapy Product Offered
Table 99. Osiris Main Business
Table 100. Osiris Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. Osiris Latest Developments
Table 102. Vericel Corporation Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 103. Vericel Corporation Immuno-Cell Therapy Product Offered
Table 104. Vericel Corporation Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. Vericel Corporation Main Business
Table 106. Vericel Corporation Latest Developments
Table 107. Fujifilm Cellular Dynamics Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 108. Fujifilm Cellular Dynamics Immuno-Cell Therapy Product Offered
Table 109. Fujifilm Cellular Dynamics Main Business
Table 110. Fujifilm Cellular Dynamics Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 111. Fujifilm Cellular Dynamics Latest Developments
Table 112. JCR Pharmaceuticals Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 113. JCR Pharmaceuticals Immuno-Cell Therapy Product Offered
Table 114. JCR Pharmaceuticals Main Business
Table 115. JCR Pharmaceuticals Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 116. JCR Pharmaceuticals Latest Developments
Table 117. Beike Biotechnology Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 118. Beike Biotechnology Immuno-Cell Therapy Product Offered
Table 119. Beike Biotechnology Main Business
Table 120. Beike Biotechnology Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 121. Beike Biotechnology Latest Developments
Table 122. Golden Meditech Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 123. Golden Meditech Immuno-Cell Therapy Product Offered
Table 124. Golden Meditech Main Business
Table 125. Golden Meditech Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 126. Golden Meditech Latest Developments
Table 127. Guanhao Biotech Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 128. Guanhao Biotech Immuno-Cell Therapy Product Offered
Table 129. Guanhao Biotech Main Business
Table 130. Guanhao Biotech Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 131. Guanhao Biotech Latest Developments
Table 132. Beroni Group Details, Company Type, Immuno-Cell Therapy Area Served and Its Competitors
Table 133. Beroni Group Immuno-Cell Therapy Product Offered
Table 134. Beroni Group Main Business
Table 135. Beroni Group Immuno-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 136. Beroni Group Latest Developments
List of Figures
Figure 1. Immuno-Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immuno-Cell Therapy Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Immuno-Cell Therapy Market Size Market Share by Type in 2020
Figure 7. Immuno-Cell Therapy in Oncology
Figure 8. Global Immuno-Cell Therapy Market: Oncology (2016-2021) & ($ Millions)
Figure 9. Immuno-Cell Therapy in Cardiovascular Disease (CVD)
Figure 10. Global Immuno-Cell Therapy Market: Cardiovascular Disease (CVD) (2016-2021) & ($ Millions)
Figure 11. Immuno-Cell Therapy in Orthopedic
Figure 12. Global Immuno-Cell Therapy Market: Orthopedic (2016-2021) & ($ Millions)
Figure 13. Immuno-Cell Therapy in Wound Healing
Figure 14. Global Immuno-Cell Therapy Market: Wound Healing (2016-2021) & ($ Millions)
Figure 15. Immuno-Cell Therapy in Others
Figure 16. Global Immuno-Cell Therapy Market: Others (2016-2021) & ($ Millions)
Figure 17. Global Immuno-Cell Therapy Market Size Market Share by Application in 2020
Figure 18. Global Immuno-Cell Therapy Revenue Market Share by Player in 2020
Figure 19. Global Immuno-Cell Therapy Market Size Market Share by Regions (2016-2021)
Figure 20. Americas Immuno-Cell Therapy Market Size 2016-2021 ($ Millions)
Figure 21. APAC Immuno-Cell Therapy Market Size 2016-2021 ($ Millions)
Figure 22. Europe Immuno-Cell Therapy Market Size 2016-2021 ($ Millions)
Figure 23. Middle East & Africa Immuno-Cell Therapy Market Size 2016-2021 ($ Millions)
Figure 24. Americas Immuno-Cell Therapy Market Size Market Share by Country in 2020
Figure 25. Americas Immuno-Cell Therapy Market Size Market Share by Type in 2020
Figure 26. Americas Immuno-Cell Therapy Market Size Market Share by Application in 2020
Figure 27. United States Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 28. Canada Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 29. Mexico Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 30. APAC Immuno-Cell Therapy Market Size Market Share by Regions in 2020
Figure 31. APAC Immuno-Cell Therapy Market Size Market Share by Type in 2020
Figure 32. APAC Immuno-Cell Therapy Market Size Market Share by Application in 2020
Figure 33. China Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 34. Japan Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 35. Korea Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 36. Southeast Asia Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 37. India Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 38. Australia Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 39. Europe Immuno-Cell Therapy Market Size Market Share by Country in 2020
Figure 40. Europe Immuno-Cell Therapy Market Size Market Share by Type in 2020
Figure 41. Europe Immuno-Cell Therapy Market Size Market Share by Application in 2020
Figure 42. Germany Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 43. France Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 44. UK Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 45. Italy Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 46. Russia Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 47. Middle East & Africa Immuno-Cell Therapy Market Size Market Share by Region in 2020
Figure 48. Middle East & Africa Immuno-Cell Therapy Market Size Market Share by Type in 2020
Figure 49. Middle East & Africa Immuno-Cell Therapy Market Size Market Share by Application in 2020
Figure 50. Egypt Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 51. South Africa Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 52. Israel Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 53. Turkey Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 54. GCC Country Immuno-Cell Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 55. Americas Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 56. APAC Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 57. Europe Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 58. Middle East & Africa Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 59. United States Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 60. Canada Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 61. Mexico Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 62. Brazil Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 63. China Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 64. Japan Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 65. Korea Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 66. Southeast Asia Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 67. India Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 68. Australia Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 69. Germany Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 70. France Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 71. UK Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 72. Italy Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 73. Russia Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 74. Spain Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 75. Egypt Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 76. South Africa Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 77. Israel Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 78. Turkey Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Figure 79. GCC Country Immuno-Cell Therapy Market Size 2021-2026 ($ Millions)
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets